Factor VIII inhibitors.
Lollar
P
P
Department of Medicine, Emory University, Atlanta GA 30322, USA.
Healey
J F
JF
Barrow
R T
RT
Parker
E T
ET
D000328:Adult; D000818:Animals; D001323:Autoantibodies / Q000096:biosynthesis / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology; D000939:Epitopes / Q000276:immunology; D005169:Factor VIII / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism / Q000627:therapeutic use; D005260:Female; D006467:Hemophilia A / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D007518:Isoantibodies / Q000096:biosynthesis / Q000276:immunology*; D008297:Male; D016297:Mutagenesis, Site-Directed; D011247:Pregnancy; D017434:Protein Structure, Tertiary; D011644:Puerperal Disorders / Q000276:immunology; D013552:Swine / Q000276:immunology; D014841:von Willebrand Factor / Q000378:metabolism
D001323:Autoantibodies; D000939:Epitopes; D007518:Isoantibodies; D014841:von Willebrand Factor; D005169:Factor VIII